Shout-out here to Immuron. $1.5 billion market opportunity. Immuron's drug is already on the market! Amazon reviews off the charts. Passport Health recommends Travelan as the go-to preventative food & water-borne GI illness drug.
It's all coming together. GSK bought out the company I posted about a day or two ago for $215 million U.S. for a promising Phase 1 Shigella vaccine drug.
Undervalued a bit lol?!
Shout-out here to Immuron. $1.5 billion market opportunity....
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.79M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 51067 | 1 |
View Market Depth
| Last trade - 16.12pm 03/10/2024 (20 minute delay) ? |
| IMC (ASX) Chart |
Day chart unavailable